Medtronic gains FDA nod for artificial pancreas device

09/30/2013 | Star Tribune (Minneapolis-St. Paul, Minn.)

The FDA has granted Medtronic approval for its MiniMed 530G with Enlite system, which the company said is the first artificial pancreas device that stops insulin delivery automatically when the patient's blood sugar falls to preset levels. The device, designed for diabetes patients 16 years or older, will be available commercially in the next few weeks.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
PRINCIPAL ENGINEER - R&D - 14000009CP
Abbott
Chicago, IL
Medical Director - Physician
Willamette Valley Community Health
Salem, OR